Novoclem announces CEO Anne Whitaker to present at the BIO CEO & Investor Annual Conference on Monday February 12th, 2018

Novoclem Therapeutics, a preclinical-stage pharmaceutical company focused on helping people who suffer from severe respiratory diseases to breathe better and live life more fully, today announced that it will present at the Bio CEO & Investor Conference, to be held February 12th–13th at the New York Marriott Marquis.